Leqembi maintenance dose filed in US, but SC form delayed April 1, 2024 AutoBot News 0 Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance dosing regimen that would reduce the number of intravenous infusions needed to one per month.